West Pharmaceutical Services (WST) Dividends Paid - Common (2009 - 2026)

West Pharmaceutical Services (WST) has reported Dividends Paid - Common for 18 consecutive years, with $15.7 million the latest figure, recorded in Q2 2026.

• Quarterly Dividends Paid - Common rose 3.97% year-over-year to $15.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $62.4 million (up 3.83% YoY) and the FY2025 annual result came in at $61.2 million, up 3.55% from the prior year.
• Dividends Paid - Common fell to $15.7 million in Q2 2026 per WST's latest filing, from $15.8 million in the prior quarter.
• Over the last five years, Dividends Paid - Common for WST reached as high as $15.8 million in Q4 2025 and fell as low as $13.1 million in Q2 2022.
• A 5-year average of $14.6 million and a median of $14.6 million in 2024 frame the typical range for Dividends Paid - Common.
• Annual changes were most pronounced in 2023 — Dividends Paid - Common gained 7.63% — and 2025, when it increased 3.27%.
• Year by year, Dividends Paid - Common stood at $14.1 million in 2022, then gained by 4.96% to $14.8 million in 2023, then gained by 3.38% to $15.3 million in 2024, then rose by 3.27% to $15.8 million in 2025, then dropped by 0.63% to $15.7 million in 2026.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered $15.7 million, $15.8 million, and $15.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.